PFA pursuant to regulation 33 of Listing Regulations, herewith Audited Financial Results (Standalone & Consolidated) for the Quarter ended 31.03.2026 along with statement of Assets & Liabilities ....
Awaiting price reaction for this filing.
Uniworth International Limited reported audited financial results for FY 2026 with a Qualified Opinion from auditors Khandelwal Ray & Co. The company posted a net loss of Rs. 157.01 Lacs for both standalone and consolidated figures. Revenue from operations was zero/minimal as the company disclosed that business activities have been suspended since long. The auditors flagged non-provision for doubtful debts totaling over Rs. 3,300 Lacs, including Rs. 3,010.57 Lacs in overdue export bills and Rs. 227.73 Lacs in claims from banks. For consolidated results, auditors were denied access to subsidiary Uniworth Biotech Limited, raising concerns about the Rs. 4.93 Lacs investment value. The company also did not recognise deferred tax assets despite consistent losses. Four qualified opinion audit qualifications are repetitive in nature.
The Qualified Opinion and multiple audit qualifications signal weak financial controls and potential overstatement of assets. The company's suspended operations and accumulated losses of Rs. 3,425.13 Lacs (negative net worth) make this a high-risk investment. Shareholders should exercise extreme caution given the qualified audit reports and inability to verify subsidiary financials.